The original scoring provides options 15 for each item, with 1 meaning no limitation and 5 meaning extreme limitation on the gaitrelated item. The aim of this study was to crossculturally adapt and validate the msws12. Walking assessments had high reliability and were correlated with related measures, including the 12item multiple sclerosis walking scale msws12. Brain sciences free fulltext cortical excitability. The msws12 was used as to validate the clinical significance of changes in walking speed as measured by the timed 25foot walk t25fw in a phase 3 randomized, controlled trial of. The effects of exergaming on balance, gait, technology.
Gait assessment for multiple sclerosis patients using. The 12item ms walking scale msws12 assesses patients measurement of walking quality. To map the 12item multiple sclerosis walking scale msws12 onto the euroqol 5dimension eq5d healthutility index in multiple sclerosis ms patients participating in the north american research committee on multiple sclerosis narcoms registry. Crosscultural adaptation and validation of the 12item. The 12item multiple sclerosis walking scale 12msws is a validated questionnaire which assessed walking function. The 12item multiple sclerosis walking scale msws12 provides a patientreported outcome of the impact of ms on walking. Full text mapping of multiple sclerosis walking scale. Longitudinal changes in selfreported walking ability in.
Mapping the 12item multiple sclerosis walking scale to the euroqol. One hundred fortynine patients in the community and 53 hospital outpatients with ms completed the msws12 and other outcome measures. The 12item multiple sclerosis walking scale msws 12 what does this author special investigating alternative medicine but in many cases most patients to ever be truly better improving the patient has been brought on by facial movements through even with associated with multiple sclerosis before contract. Assessment of clinically meaningful improvements in self. Findings from the multinational enhance study in walking disabled participants with multiple sclerosis expanded disability status scale edss score 4. Preliminary psychometric evaluation data quality, scaling assumptions, acceptability, reliability, validity. Twelve item ms walking scale msws12 sailing sclerosis. Estimation of the effect of dalfampridineer on health.
Pdf mapping of multiple sclerosis walking scale msws12 to. Each item can be answered with 5 options, with 1 meaning no limitation and 5 extreme limitation. The higher the scorepercentage, the greater the perceived impact ms is having on walking ability. Background patientreported outcomes are increasingly used to understand the clinical meaningfulness of multiple sclerosis disability and its treatments. To develop a patientbased measure of walking ability in ms. The scale has not been independently validated for use in differing ms populations. A conversation with your doctor about walking difficulty might be an important first step. We also offer guidance on diet, support groups and assistive devices. It consists of 12 questions concerning the limitations to walking due to ms during the past 2 weeks. The first 12 questions of this guide are based on the 12item multiple sclerosis walking scale msws12a validated, selfreported patient questionnaire rating the effect of ms on walking. Doctor discussion guide talking about walking ampyra. The 12item multiple sclerosis walking scale msws12 is a selfreport measure of the impact of ms on. A plot of the observed and predicted eq5d values is provided in figure 1. Used to improve walking in patients with multiple sclerosis ms.
There are many measures of walking impairment that have been included in research and clinical practice such as the expanded disability status scale edss, timed walk tests e. The multiple sclerosis rating scale, revised msrsr. However, these clinical scores are subjective and are unable to detect subtle changes in a subjects gait due to the progression of the disease or the response to treatment. Mapping of multiple sclerosis walking scale msws12 to five. Mapping the 12item multiple sclerosis walking scale to the. Multiple sclerosis walking scale12 and oxygen cost of. Most multiple sclerosis ms patients will develop walking limitations during the disease. Monitoring longterm efficacy of fampridine in gaitimpaired patients. Pdf development of a gait module to complement the 12. Evaluating walking in patients with multiple sclerosis. The aim of this study was to crossculturally adapt and validate the msws12 for the italian population with ms. The dynamic gait index and the timed up and go test involve other aspects of mobility, including balance. In a version 2, three items are scored, and nine items are.
In the 12item multiple sclerosis walking scale msw12, a selfrated measure of walking ability, timed walkresponders on fampridine reported feeling less disabled in daily activities requiring. Mapping the 12item multiple sclerosis walking scale to. The psychometric properties of the msws12 were excellent, and in. Dalfampridine was formerly known as fampridine 4aminopyridine. Twelve item ms walking scale msws 12 graph patient progress over time twelve item ms walking scale use the graphs below to plot the percentage score from the questionnaire at each visit. Multiple sclerosis ms is a progressive neurologic disease that is.
The 12item multiple sclerosis walking scale msws12 is a new, selfrated measure of walking ability. Natalizumab treatment for secondary progressive multiple sclerosis did not reduce progression on the primary multicomponent disability endpoint in part 1, but it did reduce progression on its upperlimb component. Crosssectional msws12 to eq5d cross walking analysis. Objective to map the 12item multiple sclerosis walking scale msws12 onto the. The kurtzke expanded disability status scale offers doctors and researchers a way to rate multiple sclerosis disability, but experts.
Background and objective the 12item multiple sclerosis walking scale msws12 is a patientreported outcome instrument that quantifies the progressive loss of walking. Multiple sclerosis or ms is a chronic, often disabling disease that causes damage in the central nervous system brain and spinal cord. The aim of this study was to examine the reliability and validity of the msws12 in persian speaking patients with ms. Italian validation of the 12item multiple sclerosis. The 12item multiple sclerosis walking scale msws12 is a validated rating scale that captures patients perceptions of the impact of ms on walking ability. Measuring the impact of ms on walking ability neurology. Gait impairment is reported by 85% of patients with multiple sclerosis ms as main complaint. Higher scores indicate a greater impact on walking than lower scores. In developing the patientslikeme online platform for patients with multiple sclerosis ms, we required a patientreported assessment of functional status that was easy to complete and identified disability in domains other than walking.
The multiple sclerosis walking scale is a selfassessment scale which measures the impact of ms on walking. The 12item multiple sclerosis walking scale msws12 is a patientreported outcome instrument that quantifies the progressive loss of walking ability from the patient perspective. Profiling walking dysfunction in multiple sclerosis. Multiple sclerosis impact scale msis29 the following questions ask for your views about the impact of ms on your daytoday life during the past two weeks for each statement, please circle the one number that best describes your situation please answer all questions in the past two weeks, how much has. Gait impairment is commonly in people with multiple sclerosis ms. Of the instruments available, the clinicianobserved timed 25foot walk and patient selfreport 12item multiple sclerosis walking scale have properties that make them suitable for routine evaluation of walking performance. The multiple sclerosis walking scale msws12 was developed to measure the impact of multiple sclerosis on walking. We focus on medical treatments and therapies for building strength, motor function and communication. The 12item multiple sclerosis walking scale msws12 is a selfreport measure of the impact of ms on the individuals walking ability. The 12item multiple sclerosis walking scale msws12 is a patientreported outcome measure that assesses patients perception of the impact of ms on walking ability. Multiple sclerosis a simple walking test tracks ms progress the time it takes to walk 25 feet reveals a surprising amount about a persons level of disability due to ms. The 12item multiple sclerosis walking scale msws12 is a.
Multiple sclerosis outcome measures taskforce compendium of instructions for outcome measures 12. The 12item multiple sclerosis walking scale msws12 is a selfreport measure of the impact of ms on the. Symptoms may be mild, such as numbness in the arms and legs, or severe, such as paralysis or loss of vision. Siponimod for the treatment of secondary progressive. Walking impairment is a common marker of disease progression in individuals with multiple sclerosis ms. Pdf background although multinational clinical trials frequently use patient reported. Objective we studied longitudinal changes in walking ability using. Original research paper development of a gait module to. Pdf italian validation of the 12item multiple sclerosis. Effect of natalizumab on disease progression in secondary. Confirming the validity and responsiveness of the multiple. Sustainedrelease oral fampridine is the only approved drug that will improve gait in a subset of ms patients. Assessing walking disability in multiple sclerosis.
For example, the 12item multiple sclerosis walking scale msws12 measures the patientreported impact of the disease on walking ability. Pdf testing patientreported outcome measurement equivalence. Scatterplot of observed versus predicted eq5d3l scores for the der401. Most patients with multiple sclerosis ms eventually experience walking disability. The 12item multiple sclerosis walking scale msws 12 is a patientreported outcome that assesses the impact of walking impairment in people with ms. Hobart jc, riazi a, lamping dl, fitzpatrick r, thompson aj.
Most gait problems can be helped to some extent by physical therapy, stretching exercises, the use of appropriate assistive devices and, in some cases, medications for spasticity, fatigue, and walking speed e. An equation for mapping the msws12 to the eq5d was previously developed and validated using a north american research committee on ms narcoms registry cohort. A simple walking test tracks ms progress everyday health. Ms multiple sclerosis mri magnetic resonance imaging msfc multiple sclerosis functional composite msis29 multiple sclerosis impact scale msws12 12item multiple sclerosis walking scale ncd national coverage determination nice national institute for health and care excellence nnt number needed to treat nr not reported or odds ratio. We sought to evaluate the effect of dalfampridineer tablets prolongedrelease fampridine in europe on health utility in patients with multiple sclerosis ms by mapping subjects individual item scores from the 12item multiple sclerosis walking scale msws12 onto the euroqol 5dimension eq5d health utility index. The multiple sclerosis walking scale 12 msws12 is a multiitem rating scale used to assess the perspectives of patients about the impact of ms on their walking ability. Identification and validation of clinically meaningful. Figure 1 scatterplot of observed versus predicted eq5d3l scores for the. Walking impairment has o en been measured in clinical research and practice using the expanded disability status scale edss,thetimedfootwalktfw, theminute walk mw, and quantitative analysis gait kinematics. People with multiple sclerosis ms come to us for inpatient, outpatient or day rehabilitation. Full text mapping of multiple sclerosis walking scale msws12 to. However, previous psychometric analyses indicated floor and ceiling effects across the multiple sclerosis severity spectrum. This study aimed to profile gait pathology in gaitimpaired patients with ms using comprehensive 3d gait analysis and.
Acorda therapeutics ms drug ampyra could stumble cbs news. The 12item multiple sclerosis walking scale msws12 is a patientreported outcome measure that assesses patients perception of the impact of multiple sclerosis ms on walking ability, but cannot be used in costeffectiveness or costutility analyses which require a healthutility score to calculate qualityadjusted lifeyears. Existing measures of functional status were inadequate, clinicianreported, focused on walking, and burdensome to complete. Longerterm trials are needed to assess whether treatment of secondary progressive multiple sclerosis might produce benefits on additional disability components.
540 818 1494 437 584 966 946 89 29 426 278 95 1399 1138 1010 959 757 425 932 86 666 642 839 449 277 568 1141 428 135 1451 906 321 964 1324 1063 1458 1376 1165 178 1337 1313 670 412 77